Case 1:18-cv-00924-CFC Document 390 Filed 10/03/19 Page 1 of 212 PageID #: 28995
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`
`
`GENENTECH, INC.,
`
`v.
`
`AMGEN INC.,
`
`Plaintiff,
`
`Defendant.
`
`
`
`
`
`
` C.A. No. 18-924-CFC
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`NOTICE OF SERVICE OF SUBPOENAS
`
`PLEASE TAKE NOTICE that Plaintiff Genentech, Inc. will serve the subpoenas attached
`
`hereto.
`
`
`ME1 31600648v.1
`
`

`

`Case 1:18-cv-00924-CFC Document 390 Filed 10/03/19 Page 2 of 212 PageID #: 28996
`
`
`
`MCCARTER & ENGLISH, LLP
`
` /s/ Daniel M. Silver
`Michael P. Kelly (#2295)
`Daniel M. Silver (#4758)
`Alexandra M. Joyce (#6423)
`Renaissance Centre
`405 N. King Street, 8th Floor
`Wilmington, DE 19801
`(302) 984-6300
`mkelly@mccarter.com
`dsilver@mccarter.com
`ajoyce@mccarter.com
`
`Counsel for Plaintiff Genentech, Inc.
`
`
`
`
`
`Dated: October 3, 2019
`
`Of Counsel:
`
`William F. Lee
`Lisa J. Pirozzolo
`Emily R. Whelan
`Kevin S. Prussia
`Andrew J. Danford
`Timothy A. Cook
`Stephanie Neely
`WILMER CUTLER PICKERING
`HALE AND DORR LLP
`60 State Street
`Boston, MA 02109
`(627) 526-6000
`
`Robert J. Gunther Jr.
`WILMER CUTLER PICKERING
`HALE AND DORR LLP
`7 World Trade Center
`250 Greenwich Street
`New York, NY 10007
`(212) 230-8800
`
`Daralyn J. Durie
`Adam R. Brausa
`DURIE TANGRI LLP
`217 Leidesdorff St.
`San Francisco, CA 94111
`(415) 362-6666
`
`
`ME1 31600648v.1
`
`

`

`Case 1:18-cv-00924-CFC Document 390 Filed 10/03/19 Page 3 of 212 PageID #: 28997
`
`  
`

 
`
`
`
` !" "!!
`#$
`
`%%%%%%%%%%#%%%%%%%%%%
`ƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒ„…†‡ˆ…‰‡ƒŠ‹ƒ„ŒŽŽˆŒ
`
`‘’‘’“‘”•–—˜’”™
`&'()*+),,
`
`¢£¤‘’—˜’”™
`
`-.,.*/(*+
`
`
`
`
`
`
`
`
`
`
`  
`
`š›œžŸœ ¡ 
`
`0123456789489509:;<879878=5340:9:468:6878>:?:@87>9:46
`
`A
`
` ¥’”‘¦—¥’§—¨©ªª§—«¬‘”­¥©“®— ©­’­”—
`¯›°š—±¥“‘©©¥—¢²‘—³šž°–—´ªµ—¢©¥£­“ªµ–— ¢—¶·ž¶
`BC(D.EF,EG.HIF*E+FEJKFDE+K)IEILMGF.*(E)IE/)H.N+./O
`
`¸
`P Q.I+)DF*RS<4187T58>4UU76=5=#$VWXWX#$Y
`XZ$!##[\WVX[#V##WX##W
`#V[[[W#X[$##Y$#$$Y[V#W#
`$#$$VA
`«‘‘—«”•‘§¹©‘—¨™
`
`
`
`º­©£‘¦— ¹“©‘¦—»­”¼‘¦­’¤—½¥©‘—¾—¿ª¦¦—´´»—
`]A
`¯°¶—«™—¦¥’§—¢²‘—³žš¶¶—
`´ªµ—¢’¤‘©‘µ–— ¢—¶¶·š
`
`XVA
`š¶ÀšŸÀž¶š—Á¶¶—¥£
`
`$XY##XX$V$XA
`
`­§‘ª¤¦¥¬•‘¦—¥’§—µ“‘’ª¤¦¥¬•‘¦
`
`P &HF/LN+)F*S^W####WV#[Y$$X$Y[XVW
`##X#VW#_WXV#VW[W[W#V[$
`V#A
`
`$Y[#`X]ab#$Xcab W#[$Vd
`abX W#[###_dXab X[ W#[#X
`#X$X$eX[
`
`A
`
`š¶À¶¯Àž¶š
`
`fghijEklEfkmiQ
`
`n)o*(+LH.EF,Ef'.HpEFHE-.GL+REf'.Hp
`
`
`
`ÀµÀ—ꦥ—ęř—»¥µµ¥£¥’‘”¼
`q++FH*.RrIEI)o*(+LH.
`
`$VWXX#WsVXX#WX$V#$###[B*(D.EF,EG(H+RO
`WY$##e$W#A
`
`‘’‘’“‘”•–—˜’”™
`
`ꦥ—ęř—»¥µµ¥£¥’‘”¼–—’ª¦¥™¬¥µµ¥£¥’‘”¼ÆÇ­©£‘¦•¥©‘™”ª£–—È·ž¶É—ž·Ÿœ¯š¯°—
`šžž°—«‘²‘’“‘‘’“•—«“™–—«¹­“‘—žÊ¶¶–—¿‘’²‘¦–— Ë—›¶ž¶ž
`
`6tuvwx8ut8uyx8zx{|t}8~yt8v||x|8t{8{x€x|u|8uyv|8|ztx}‚
`!$VVX$#XXVW##X#VW#[$[W
`X$V#X$#$##X$#Y$V
`X#X`X]ab a 
`
`

`

`Case 1:18-cv-00924-CFC Document 390 Filed 10/03/19 Page 4 of 212 PageID #: 28998
`Case 1:18—cv-00924-CFC Document 390 Filed 10/03/19 Page 4 of 212 PageID #: 28998
`A0 88A Rev. 12/13) Subpoena to Testify at a Deposition in a Civil Action (Page 2)
`  
`

 ][
`
`
`Civil Action No. 18'924-CFC
`š›œžŸœ ¡ 
`
`  
`
`PROOF OF SERVICE
`3T44;84;805T?:>5
`(This section should not befiled with the court unless required by Fed. R. Civ. P. 45.)
`ÌÍÎÏÐÑÐÒÓÔÏÕÖÑÐÎÕ×ØÙÑÖÕÔÑÚÒÑÛÏØÒÙÑÜÏÔÎÑÔÎÒÑÓÕ×ÝÔÑ×ÖØÒÐÐÑÝÒÞ×ÏÝÒÙÑÚßÑàÒÙáÑâáÑãÏäáÑåáÑæçáè
`
`
`I received this subpoena for (name ofindividual and title, ifany)
`!#X$#B*(D.EF,E)*/)é)/L('E(*/E+)+'.êE),E(*RO
`on (date)
`B/(+.O
`
`
`El I served the subpoena by delivering a copy to the named individual as follows:
`P !#X$X#[$VXXXYA
`
`
`
`
`
` on (date) ; 01‘
`B/(+.O
`d#
`
`
`El I returned the subpoena unexecuted because:
`P !##X$ëXA
`
`
`
`
`Unless the subpoena was issued on behalf of the United States, or one of its officers or agents, I have also
`$YX$$XW###[W!$
`tendered to the witness the fees for one day’s attendance, and the mileage allowed by law, in the amount of
`X#X$Y$#XìXWX$V[YXYW$V
`$
`í
`
`
`
`My fees are $
`î#í
`
`
`
`for travel and $
`##Xí
`
`for services, for a total of $
`##W#í
`
`0.00
`¶™¶¶
`
`
`
`I declare under penalty of perjury that this information is true.
`!X#X##_#$$#V#
`
`Date:
`A
`
`
`
`Server ’s signature
`n.Hé.HrIEI)o*(+LH.
`
`
`Printed name and title
`&H)*+./E*(D.E(*/E+)+'.
`
`
`
`Server ’s address
`n.Hé.HrIE(//H.II
`
`Additional information regarding attempted service, etc.:
` XX#V#[#X[VX#WA
`
`

`

`Case 1:18-cv-00924-CFC Document 390 Filed 10/03/19 Page 5 of 212 PageID #: 28999
`
`  
`

 ][

`
`;xïx{‚ð8Tðx8tñ8>vòvð83{twxï{x8óô8õwö÷8õïö÷8õxö÷8‚}ï8õøö8õ5ññxwuvòx8ùúûùûùüö
`
`õwö83ð‚wx8tñ8>týzðv‚}wxþ
`
`88õùö8àÕÝÑÑÍÝÏØ ÑÒÝÏÖ ÑÕÝÑÒÕÐÏÔÏÕÖáE VVVX
`#X#W$#[W#XYA
`8888õ7öY$ VY$#$##XWVXW#
`#[###d#
`8888õ2öY$$Y$#$##XWVXW##[#
`##W$#
`88888888õvö###ì#d#
`88888888õvvöVVXXX#XYX#
`ë
`
`88õúö8àÕÝÑÔÎÒÝÑÏÐÓÕäÒÝßáE VVVXA
`8888õ7ö#XXVW##X#VW#
`[$[Y$ VY$#$##XW
`VXW##[###dX
`8888õ2ö#V$#VX
`
`õïö83{tuxwuv}ø8‚83x{|t}80xwu8ut8‚80ztx}‚ 85}ñt{wxýx}uþ
`
`88õùö8
`äÕÏÙÏÖ ÑÖÙ×ÒÑ

×ÝÙÒÖÑÕÝÑ ÒÖÐÒÑÖÓÔÏÕÖÐáE ###
`##[X#[VZ#
`XV[X#X#ë#_$
`$##$X#Y$#V#e#XV
`#$XXV##Y$$VX
`#[X##ì###Y$
`V
`
`
`
`88õúö8ãÕÖÙÑÔÕÑåÝÕÙ×ÓÒÑÔÒÝÏØÐÑÕÝÑåÒÝÏÔÑÖÐÒÓÔÏÕÖá
`õ7öqGG.(H(*N.ECF+Ei.L)H./E #VVXX#X
`XVW##X#VW#[$[W#
`#V$#VWX##$
`#X#VVXX##XW
`$#[W##
`õ2ökM.N+)F*IE #VVXX#XXV#[
`$[##VV#$###X[X
`$Y#_[W[W[W#
`V[#$V##[$#V#
`#X[##X#V$#V##V#eX
`$_V#X#$##$VX#
`V# aX#$#X!_VXW
`$Y[#A
`õvö VW$VVXX#W$#[#
`VV$##$X#Y$#V#e#X#
`#X#V[#X#
`88õvvö$V#e#XX#X$#X#WX$
`#X#V##Y$$####ì##V
`[ë#[#VV
`
`88õüö8×ÐÎÏÖ ÑÕÝÑÕÙÏÛßÏÖ ÑÑ×ÚÕÒÖá
`
`õ7öK.*Ei.L)H./EVVW$##$X#Y$#
`V#e#XVe$#VX$A
`
`88888888õvöY#VVd
`õvvö#e##VX$[[#$V
`Xab d
`õvvvö#e#X##[X#$##XV#W
`ë#Y#d#
`õvòö_#X#X
`õ2öK.*E&.HD)++./E##_#X
`W$##$X#Y$#V#e#XVW
`VWe$#VX$#e#A
`
`õvöX[#X##$#X##$WXVW
`#VV##Vd#
`õvvöX[#Xë#ì##V$X
`X###XX##V$ë#ì
`X$Y#eX#
`õ>önG.N),R)*oEfF*/)+)F*IE(IE(*Eq'+.H*(+)é.E!$#V
`X#XabX 

 W$#VWXe$[#
`VX[W#X####XX#X
`X$#[#A
`õvö$YX#$V#V#$
`$#YVY$X$#X$dX
`õvvö#$$X#Y#VX
`
`õxö8=uvx|8v}8Tx|zt}ïv}ø8ut8‚80ztx}‚þ
`
`88õùö8åÝÕÙ×ÓÏÖ ÑÕÓ×ÒÖÔÐÑÕÝÑ ØÒÓÔÝÕÖÏÓØØßÑÔÕÝÒÙÑÖÛÕÝÔÏÕÖáE$
`#X##X[XV###X
`#VA
`õ7ö-FNLD.*+IE ##X[#XXV
`V#X$V$#Z$#X###
`V#[\X$V##X$[#$XVX
`õ2ölFHDE,FHE&HF/LN)*oEh'.N+HF*)N(''REn+FH./E*,FHD(+)F*ECF+EnG.N),)./
`!X#V##X[##X
`#VW$##X[V#X#V##V
`Y$$#X#VX###V##V
`õ>öh'.N+HF*)N(''REn+FH./E*,FHD(+)F*E&HF/LN./E)*Ek*'REk*.ElFHDE$
`##X[X#X$V##X
`#VV#$#V
`õ=ö*(NN.II)M'.Eh'.N+HF*)N(''REn+FH./E*,FHD(+)F*E$#
`#X[X#XX###X#V
`#V#$$#X#
`X#X#VVX####
`#X#W$##X[V$Y$$#V
`#X#X#!$$Y[
`VXW$#V$#X#X##V$#$
`#e[#$Y[XWX#[$V
`
`
` 
`  $#VX#$X#
`
`õúö8ãØÏÏÖ ÑåÝÏäÏØÒ ÒÑÕÝÑåÝÕÔÒÓÔÏÕÖá
`õ7ö*,FHD(+)F*E)+KK.'/E #Y$$X[X#V
`X#V$#[X#_##s##
`V#VA
`õvöë#VZ$VdX
`õvvöX#$#$Y$$XXVWVVW#
`[$[V#$WY$#[#V
`#[X##XWY$#$V
`õ2ö*,FHD(+)F*E&HF/LN./E!#V#XX#
`_V#[##
`#s##V#W$#VZ[$VV#
`$#X$#V$VX$# #[
`XW#V#V##We#W#X#$X
`#VX$dV#X$#V
`$V#XdVZ###$
`#V$#XX#[XdXV#V
`#$#VX#$##$X#Y$#
`V#e#X#X#V$V$#Y$
`#XX$#VV##$#V$V
`#X
`
`õøö8>t}uxýzuþ
`$##$X#Y$#V#e#XXW#
`V###XW$[#V$XV#
`Y$W$[#XWY$Xeë$
`##X##X
`
``#V#W`X]ab VV 
`


`
`

`

`Case 1:18-cv-00924-CFC Document 390 Filed 10/03/19 Page 6 of 212 PageID #: 29000
`
` !"#$%&'()*+,-./01$23415617.8$918.:$24;<=2>16:34?12<16/@$84;16415$6:?4=2;0$84?121>56$:?;$;?23A?%?B84?12
`
`CD=EF9-EEF-9=-E#=AEAC#E
`>164G$
`
`ƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒ„…†‡ˆ…‰‡ƒŠ‹ƒ„ŒŽŽˆŒ
`HHHHHHHHHH9?;46?841>HHHHHHHHHH
`
`A?%?B84?12D1&
`
`š›œžŸœ ¡ 
`
`, , , , , ,
`
`‘’‘’“‘”•–—˜’”™
`
`IJKLMNLOO
`%&
`¢£¤‘’—˜’”™
`
`PQOQMRKMN
`
`STUVWXYZ[\W[V]W^T_X[^W_T`XY\Sa[bYcW]`Z\bWYa[W][WUdX_\S
`W][\W[VX]`b\[bYSVX_\bWY[Wc[V]X`bSXSbYZ[_bebf[Z_\bWY[
`
`E1g
`
` ¥’”‘¦—¥’§—¨©ªª§—«¬‘”­¥©“®— ©­’­”—
`¯›°š—±¥“‘©©¥—¢²‘—³šž°–—´ªµ—¢©¥£­“ªµ–— ¢—¶·ž¶
`hiKjQklOkmQnolMkNlkpqljkNqLokorsmlQMKkLokRLnQtNQRu
`
`¡
`v InlRrtNLlMwxWT[Z]X[_W``ZY^X^[410617.8$344G$4?:$<734$<3270B38$;$4>164G/$B1y4G$>1BB1y?2z
`718.:$24;<$B$84612?83BB{;416$7?2>16:34?12<161/@$84;<327410$6:?4?2;0$84?12<810{?2z<4$;4?2z<16;3:0B?2z1>4G$
`¢££¤¢¥¦£§¨©£¤ª
`:34$6?3Bg
`
`5B38$g
`º­©£‘¦— ¹“©‘¦—»­”¼‘¦­’¤—½¥©‘—¾—¿ª¦¦—´´»—
`¯°¶—«™—¦¥’§—¢²‘—³žš¶¶—
`´ªµ—¢’¤‘©‘µ–— ¢—¶¶·š
`
`934$327E?:$g
`
`š¶ÀšŸÀž¶š—Á¶¶—¥£
`
`v |MomQtNLlMklOkInQjLoQowxWT[Z]X[_W``ZY^X^410$6:?4$246{12414G$7$;?z234$706$:?;$;<B327<16
`14G$60610$64{01;;$;;$716812461BB$7/{{1.344G$4?:$<734$<327B1834?12;$4>164G/$B1y<;14G344G$6$}.$;4?2z0364{
`:3{?2;0$84<:$3;.6$<;.6%${<0G141z630G<4$;4<16;3:0B$4G$0610$64{1632{7$;?z234$71/@$841610$634?1212?4&
`
`5B38$g
`
`934$327E?:$g
`
`EG$>1BB1y?2z061%?;?12;1>~$7&#&A?%&5&+36$34438G$7€#.B$+"8,<6$B34?2z414G$0B38$1>81:0B?328$
`#.B$+"7,<6$B34?2z41{1.60614$84?123;30$6;12;./@$84413;./01$23327#.B$+"$,327"z,<6$B34?2z41{1.67.4{41
`6$;0127414G?;;./01$233274G$014$24?3B812;$}.$28$;1>21471?2z;1&
`
`934$g
`
`š¶À¶¯Àž¶š
`
`‚ƒ„…†k‡ˆk‚‡‰…Š
`
`‹LŒMKNrnQklOk‚JQnklnkPQmrNŽk‚JQn
`
`#
`
`ÀµÀ—ꦥ—ęř—»¥µµ¥£¥’‘”¼
`NNlnMQŽokoLŒMKNrnQ
`
`EG$23:$<3776$;;<$‘:3?B3776$;;<3274$B$0G12$2.:/$61>4G$344162${6$06$;$24?2zhMKjQklOkmKnNŽu
`<yG1?;;.$;166$}.$;4;4G?;;./01$23<36$g
`
`‘’‘’“‘”•–—˜’”™
`
`ꦥ—ęř—»¥µµ¥£¥’‘”¼–—’ª¦¥™¬¥µµ¥£¥’‘”¼ÆÇ­©£‘¦•¥©‘™”ª£–—È·ž¶É—ž·Ÿœ¯š¯°—
`šžž°—«‘²‘’“‘‘’“•—«“™–—«¹­“‘—žÊ¶¶–—¿‘’²‘¦–— Ë—›¶ž¶ž
`Y’“”•–[“’[“—–[˜–™š’›[œ—’[”šš–š[’™[™–ž–š“š[“—”š[šŸ˜’–› 
`=>4G?;;./01$2381::327;4G$0617.84?121>718.:$24;<$B$84612?83BB{;416$7?2>16:34?12<16432z?/B$4G?2z;164G$
`?2;0$84?121>06$:?;$;/$>16$46?3B<3214?8$3273810{1>4G$;./01$23:.;4/$;$6%$712$38G0364{?24G?;83;$/$>16$
`?4?;;$6%$7124G$0$6;1241yG1:?4?;7?6$84$7&~$7&#&A?%&5&+"3,"+,&
`
`

`

`Case 1:18-cv-00924-CFC Document 390 Filed 10/03/19 Page 7 of 212 PageID #: 29001
`
` !"#$%&'()*+,-./01$23415617.8$918.:$24;<=2>16:34?12<16/@$84;16415$6:?4=2;0$84?121>56$:?;$;?23A?%?B84?12"53z$(,
`
`š›œžŸœ ¡ 
`A?%?B84?12D1&
`
`V]WWc[Wc[SX]eb_X
`«¬­®¯°¯±²³®´µ°¯­´¶·¸°µ´³°¹±°º®·±¸°»®³­°³­±°²´¶¼³°¶µ·±¯¯°¼±½¶®¼±¸°¹¾°¿±¸À°ÁÀ°Â®ÃÀ°ÄÀ°ÅÆÀÇ
`
`=6$8$?%$74G?;;./01$23>16hMKjQklOkLMRLÈLRrKJkKMRkNLNJQÉkLOkKMŽu
`
`12hRKNQu
`
`&
`
`v =;$6%$74G$;./01$23/{7$B?%$6?2z3810{414G$23:$70$6;123;>1BB1y;g
`
`v =6$4.62$74G$;./01$23.2$Ê$8.4$7/$83.;$g
`
`12hRKNQu
`
`16
`
`&
`
`C2B$;;4G$;./01$23y3;?;;.$712/$G3B>1>4G$C2?4$7-434$;<1612$1>?4;1>>?8$6;163z$24;<=G3%$3B;1
`4$27$6$7414G$y?42$;;4G$>$$;>1612$73{Ë;344$27328$<3274G$:?B$3z$3BB1y$7/{B3y<?24G$3:1.241>
`
`Ì
`
`&
`
`Í{>$$;36$Ì
`
`>16463%$B327Ì
`
`>16;$6%?8$;<>1634143B1>Ì
`
`¶™¶¶
`
`&
`
`=7$8B36$.27$60$23B4{1>0$6@.6{4G344G?;?2>16:34?12?;46.$&
`
`934$g
`
`‹QnÈQnokoLŒMKNrnQ
`
`InLMNQRkMKjQkKMRkNLNJQ
`
`‹QnÈQnokKRRnQoo
`
`77?4?123B?2>16:34?126$z367?2z344$:04$7;$6%?8$<$48&g
`
`

`

`Case 1:18-cv-00924-CFC Document 390 Filed 10/03/19 Page 8 of 212 PageID #: 29002
`
`ÎÏÐÑÑÒÐÐÓÔÕÖ×ÐÐØÙÚÛÜÝÐÞßàáâÕãäÐåâÐæçâèßéÕÐêâéßëÕãåìíÐîãïâçëäåðâãíÐâçÐÏàñÕéåìÐâçÐåâÐæÕçëðåÐîãìáÕéåðâãÐâïÐæçÕëðìÕìÐðãÐäÐòðÖðóÐÎéåðâãÓæäôÕÐõÝ
`
`ö÷ø÷ùúûüýþû÷ü ü  ûüù÷øþù÷üü 
`ü ø
`ü ÷
`üú

øü
`ü  ÷ ÷ü
`
`
` 
`üûú÷ü üû ú

÷
`
`üü 
`ü !"#$!%&'"()ÎÐìßàáâÕãäÐëä*ÐéâëëäãèÐä
`áÕçìâãÐåâÐäååÕãèÐäÐåçðäóíÐ+ÕäçðãôíÐâçÐèÕáâìðåðâãÐâãó*ÐäìÐïâóóâ,ì-
`üüüü .
`Ð,ðå+ðãÐÛØØÐëðóÕìÐâïÐ,+ÕçÕÐå+ÕÐáÕçìâãÐçÕìðèÕìíÐðìÐÕëáóâ*ÕèíÐâç
`çÕôßóäçó*ÐåçäãìäéåìÐàßìðãÕììÐðãÐáÕçìâã/Ðâç
`üüüü 0
`Ð,ðå+ðãÐå+ÕÐìåäåÕÐ,+ÕçÕÐå+ÕÐáÕçìâãÐçÕìðèÕìíÐðìÐÕëáóâ*ÕèíÐâçÐçÕôßóäçó*
`åçäãìäéåìÐàßìðãÕììÐðãÐáÕçìâãíÐðïÐå+ÕÐáÕçìâã
`üüüüüüüü
`ÐðìÐäÐáäçå*ÐâçÐäÐáäçå*1ìÐâïïðéÕç/Ðâç
`üüüüüüüü
`ÐðìÐéâëëäãèÕèÐåâÐäååÕãèÐäÐåçðäóÐäãèÐ,âßóèÐãâåÐðãéßçÐìßàìåäãåðäó
`Õ2áÕãìÕ×
`
`üü 
`ü3'4!$&56!7()ÎÐìßàáâÕãäÐëä*Ðéâëëäãè-
`üüüü .
`ÐáçâèßéåðâãÐâïÐèâéßëÕãåìíÐÕóÕéåçâãðéäóó*ÐìåâçÕèÐðãïâçëäåðâãíÐâç
`åäãôðàóÕÐå+ðãôìÐäåÐäÐáóäéÕÐ,ðå+ðãÐÛØØÐëðóÕìÐâïÐ,+ÕçÕÐå+ÕÐáÕçìâãÐçÕìðèÕìíÐðì
`Õëáóâ*ÕèíÐâçÐçÕôßóäçó*ÐåçäãìäéåìÐàßìðãÕììÐðãÐáÕçìâã/Ðäãè
`üüüü 0
`ÐðãìáÕéåðâãÐâïÐáçÕëðìÕìÐäåÐå+ÕÐáçÕëðìÕìÐåâÐàÕÐðãìáÕéåÕè×
`
` ø
`üù÷

üúü÷ù8

ü9þ:;÷üüúü9þ:÷

ú<ü

ù÷÷


`
`üü 
`ü=6>"#?">@!A@>!"BC%!"&!DE"5'"&()ÎÐáäçå*ÐâçÐäååâçãÕ*
`çÕìáâãìðàóÕÐïâçÐðììßðãôÐäãèÐìÕçÖðãôÐäÐìßàáâÕãäÐëßìåÐåäFÕÐçÕäìâãäàóÕÐìåÕáì
`åâÐäÖâðèÐðëáâìðãôÐßãèßÕÐàßçèÕãÐâçÐÕ2áÕãìÕÐâãÐäÐáÕçìâãÐìßàñÕéåÐåâÐå+Õ
`ìßàáâÕãä×ÐG+ÕÐéâßçåÐïâçÐå+ÕÐèðìåçðéåÐ,+ÕçÕÐéâëáóðäãéÕÐðìÐçÕHßðçÕèÐëßìå
`ÕãïâçéÕÐå+ðìÐèßå*ÐäãèÐðëáâìÕÐäãÐäááçâáçðäåÕÐìäãéåðâãI,+ðé+Ðëä*ÐðãéóßèÕ
`óâìåÐÕäçãðãôìÐäãèÐçÕäìâãäàóÕÐäååâçãÕ*1ìÐïÕÕìIâãÐäÐáäçå*ÐâçÐäååâçãÕ*Ð,+â
`ïäðóìÐåâÐéâëáó*×
`
`üü 
`üJKK">'L>@5!M'!&L!K'N"&%!5'"(
`ÐÐÐÐ .
`ÐOPPQRSRTUQ)VWX)YQZ[\SQ]^)ÎÐáÕçìâãÐéâëëäãèÕèÐåâÐáçâèßéÕ
`èâéßëÕãåìíÐÕóÕéåçâãðéäóó*ÐìåâçÕèÐðãïâçëäåðâãíÐâçÐåäãôðàóÕÐå+ðãôìíÐâçÐåâ
`áÕçëðåÐå+ÕÐðãìáÕéåðâãÐâïÐáçÕëðìÕìíÐãÕÕèÐãâåÐäááÕäçÐðãÐáÕçìâãÐäåÐå+ÕÐáóäéÕÐâï
`áçâèßéåðâãÐâçÐðãìáÕéåðâãÐßãóÕììÐäóìâÐéâëëäãèÕèÐåâÐäááÕäçÐïâçÐäÐèÕáâìðåðâãí
`+ÕäçðãôíÐâçÐåçðäó×
`ÐÐÐÐ 0
`Ð_`aQUX\WTb^)ÎÐáÕçìâãÐéâëëäãèÕèÐåâÐáçâèßéÕÐèâéßëÕãåìÐâçÐåäãôðàóÕ
`å+ðãôìÐâçÐåâÐáÕçëðåÐðãìáÕéåðâãÐëä*ÐìÕçÖÕÐâãÐå+ÕÐáäçå*ÐâçÐäååâçãÕ*ÐèÕìðôãäåÕè
`ðãÐå+ÕÐìßàáâÕãäÐäÐ,çðååÕãÐâàñÕéåðâãÐåâÐðãìáÕéåðãôíÐéâá*ðãôíÐåÕìåðãôíÐâç
`ìäëáóðãôÐäã*ÐâçÐäóóÐâïÐå+ÕÐëäåÕçðäóìÐâçÐåâÐðãìáÕéåðãôÐå+ÕÐáçÕëðìÕìIâçÐåâ
`áçâèßéðãôÐÕóÕéåçâãðéäóó*ÐìåâçÕèÐðãïâçëäåðâãÐðãÐå+ÕÐïâçëÐâçÐïâçëìÐçÕHßÕìåÕè×
`G+ÕÐâàñÕéåðâãÐëßìåÐàÕÐìÕçÖÕèÐàÕïâçÕÐå+ÕÐÕäçóðÕçÐâïÐå+ÕÐåðëÕÐìáÕéðïðÕèÐïâç
`éâëáóðäãéÕÐâçÐÛÜÐèä*ìÐäïåÕçÐå+ÕÐìßàáâÕãäÐðìÐìÕçÖÕè×ÐîïÐäãÐâàñÕéåðâãÐðìÐëäèÕí
`å+ÕÐïâóóâ,ðãôÐçßóÕìÐäááó*-
`ÐÐÐÐÐÐÐÐ
`ÐÎåÐäã*ÐåðëÕíÐâãÐãâåðéÕÐåâÐå+ÕÐéâëëäãèÕèÐáÕçìâãíÐå+ÕÐìÕçÖðãôÐáäçå*
`ëä*ÐëâÖÕÐå+ÕÐéâßçåÐïâçÐå+ÕÐèðìåçðéåÐ,+ÕçÕÐéâëáóðäãéÕÐðìÐçÕHßðçÕèÐïâçÐäã
`âçèÕçÐéâëáÕóóðãôÐáçâèßéåðâãÐâçÐðãìáÕéåðâã×
`ÐÐÐÐÐÐüü
`ÐG+ÕìÕÐäéåìÐëä*ÐàÕÐçÕHßðçÕèÐâãó*ÐäìÐèðçÕéåÕèÐðãÐå+ÕÐâçèÕçíÐäãèÐå+Õ
`âçèÕçÐëßìåÐáçâåÕéåÐäÐáÕçìâãÐ,+âÐðìÐãÕðå+ÕçÐäÐáäçå*ÐãâçÐäÐáäçå*1ìÐâïïðéÕçÐïçâë
`ìðôãðïðéäãåÐÕ2áÕãìÕÐçÕìßóåðãôÐïçâëÐéâëáóðäãéÕ×
`
`üü 
`üc@&4"#M>d7"#E@e%!"(
`ÐÐÐÐ .
`ÐfgQT)YQZ[\SQ]^)ÏãÐåðëÕó*ÐëâåðâãíÐå+ÕÐéâßçåÐïâçÐå+ÕÐèðìåçðéåÐ,+ÕçÕ
`éâëáóðäãéÕÐðìÐçÕHßðçÕèÐëßìåÐHßäì+ÐâçÐëâèðï*ÐäÐìßàáâÕãäÐå+äå-
`üüüüüüüü
`ÐïäðóìÐåâÐäóóâ,ÐäÐçÕäìâãäàóÕÐåðëÕÐåâÐéâëáó*/
`ÐÐÐÐÐÐÐÐ
`ÐçÕHßðçÕìÐäÐáÕçìâãÐåâÐéâëáó*ÐàÕ*âãèÐå+ÕÐôÕâôçäá+ðéäóÐóðëðåì
`ìáÕéðïðÕèÐðãÐÔßóÕÐÜhÓéÝ/
`ÐÐÐÐÐÐÐÐ
`ÐçÕHßðçÕìÐèðìéóâìßçÕÐâïÐáçðÖðóÕôÕèÐâçÐâå+ÕçÐáçâåÕéåÕèÐëäååÕçíÐðïÐãâ
`Õ2éÕáåðâãÐâçÐ,äðÖÕçÐäááóðÕì/Ðâç
`ÐÐÐÐÐÐÐÐ 
`ÐìßàñÕéåìÐäÐáÕçìâãÐåâÐßãèßÕÐàßçèÕã×
`ÐÐÐ 0
`ÐfgQT)iQSj\XXQ]^)GâÐáçâåÕéåÐäÐáÕçìâãÐìßàñÕéåÐåâÐâçÐäïïÕéåÕèÐà*Ðä
`ìßàáâÕãäíÐå+ÕÐéâßçåÐïâçÐå+ÕÐèðìåçðéåÐ,+ÕçÕÐéâëáóðäãéÕÐðìÐçÕHßðçÕèÐëä*íÐâã
`ëâåðâãíÐHßäì+ÐâçÐëâèðï*Ðå+ÕÐìßàáâÕãäÐðïÐðåÐçÕHßðçÕì-
`
`ÐèðìéóâìðãôÐäÐåçäèÕÐìÕéçÕåÐâçÐâå+ÕçÐéâãïðèÕãåðäóÐçÕìÕäçé+í
`èÕÖÕóâáëÕãåíÐâçÐéâëëÕçéðäóÐðãïâçëäåðâã/Ðâç
`
`ÐÐÐÐÐÐÐÐ
`ÐèðìéóâìðãôÐäãÐßãçÕåäðãÕèÐÕ2áÕçå1ìÐâáðãðâãÐâçÐðãïâçëäåðâãÐå+äåÐèâÕì
`ãâåÐèÕìéçðàÕÐìáÕéðïðéÐâééßççÕãéÕìÐðãÐèðìáßåÕÐäãèÐçÕìßóåìÐïçâëÐå+ÕÐÕ2áÕçå1ì
`ìåßè*Ðå+äåÐ,äìÐãâåÐçÕHßÕìåÕèÐà*ÐäÐáäçå*×
`ÐÐÐÐ 
`ÐkPQU\lm\Tn)oWT]\X\WTb)Rb)RT)OpXQSTRX\qQ^)îãÐå+ÕÐéðçéßëìåäãéÕì
`èÕìéçðàÕèÐðãÐÔßóÕÐÜhÓèÝÓõÝÓÒÝíÐå+ÕÐéâßçåÐëä*íÐðãìåÕäèÐâïÐHßäì+ðãôÐâç
`ëâèðï*ðãôÐäÐìßàáâÕãäíÐâçèÕçÐäááÕäçäãéÕÐâçÐáçâèßéåðâãÐßãèÕçÐìáÕéðïðÕè
`éâãèðåðâãìÐðïÐå+ÕÐìÕçÖðãôÐáäçå*-
`ÐÐÐÐÐÐÐÐ
`Ðì+â,ìÐäÐìßàìåäãåðäóÐãÕÕèÐïâçÐå+ÕÐåÕìåðëâã*ÐâçÐëäåÕçðäóÐå+äåÐéäããâåÐàÕ
`âå+Õç,ðìÕÐëÕåÐ,ðå+âßåÐßãèßÕÐ+äçèì+ðá/Ðäãè
`ÐÐÐÐÐÐÐÐ
`ÐÕãìßçÕìÐå+äåÐå+ÕÐìßàáâÕãäÕèÐáÕçìâãÐ,ðóóÐàÕÐçÕäìâãäàó*ÐéâëáÕãìäåÕè×
`
` ÷
`ürþ ÷8ü

üý÷8

ø

üüúü9þ:÷

ú
`
`üü 
`üL>@5"#$5@K!"'&B!5'"57E'!>N"dK'"()G+ÕìÕ
`áçâéÕèßçÕìÐäááó*ÐåâÐáçâèßéðãôÐèâéßëÕãåìÐâçÐÕóÕéåçâãðéäóó*ÐìåâçÕè
`ðãïâçëäåðâã-
`ÐÐÐÐ .
`ÐsWU[jQTXb^)ÎÐáÕçìâãÐçÕìáâãèðãôÐåâÐäÐìßàáâÕãäÐåâÐáçâèßéÕÐèâéßëÕãåì
`ëßìåÐáçâèßéÕÐå+ÕëÐäìÐå+Õ*ÐäçÕÐFÕáåÐðãÐå+ÕÐâçèðãäç*ÐéâßçìÕÐâïÐàßìðãÕììÐâç
`ëßìåÐâçôäãðtÕÐäãèÐóäàÕóÐå+ÕëÐåâÐéâççÕìáâãèÐåâÐå+ÕÐéäåÕôâçðÕìÐðãÐå+ÕÐèÕëäãè×
`ÐÐÐÐ 0
`ÐuWSj)lWS)iSW][U\Tn)vpQUXSWT\URppm)kXWSQ])wTlWSjRX\WT)VWX)kPQU\l\Q]^
`îïÐäÐìßàáâÕãäÐèâÕìÐãâåÐìáÕéðï*ÐäÐïâçëÐïâçÐáçâèßéðãôÐÕóÕéåçâãðéäóó*ÐìåâçÕè
`ðãïâçëäåðâãíÐå+ÕÐáÕçìâãÐçÕìáâãèðãôÐëßìåÐáçâèßéÕÐðåÐðãÐäÐïâçëÐâçÐïâçëìÐðã
`,+ðé+ÐðåÐðìÐâçèðãäçðó*ÐëäðãåäðãÕèÐâçÐðãÐäÐçÕäìâãäàó*ÐßìäàóÕÐïâçëÐâçÐïâçëì×
`ÐÐÐÐ 
`ÐvpQUXSWT\URppm)kXWSQ])wTlWSjRX\WT)iSW][UQ])\T)_Tpm)_TQ)uWSj^)G+Õ
`áÕçìâãÐçÕìáâãèðãôÐãÕÕèÐãâåÐáçâèßéÕÐå+ÕÐìäëÕÐÕóÕéåçâãðéäóó*ÐìåâçÕè
`ðãïâçëäåðâãÐðãÐëâçÕÐå+äãÐâãÕÐïâçë×
`ÐÐÐÐ r
`ÐwTRUUQbb\`pQ)vpQUXSWT\URppm)kXWSQ])wTlWSjRX\WT^)G+ÕÐáÕçìâã
`çÕìáâãèðãôÐãÕÕèÐãâåÐáçâÖðèÕÐèðìéâÖÕç*ÐâïÐÕóÕéåçâãðéäóó*ÐìåâçÕèÐðãïâçëäåðâã
`ïçâëÐìâßçéÕìÐå+äåÐå+ÕÐáÕçìâãÐðèÕãåðïðÕìÐäìÐãâåÐçÕäìâãäàó*ÐäééÕììðàóÕÐàÕéäßìÕ
`âïÐßãèßÕÐàßçèÕãÐâçÐéâìå×ÐÏãÐëâåðâãÐåâÐéâëáÕóÐèðìéâÖÕç*ÐâçÐïâçÐäÐáçâåÕéåðÖÕ
`âçèÕçíÐå+ÕÐáÕçìâãÐçÕìáâãèðãôÐëßìåÐì+â,Ðå+äåÐå+ÕÐðãïâçëäåðâãÐðìÐãâå
`çÕäìâãäàó*ÐäééÕììðàóÕÐàÕéäßìÕÐâïÐßãèßÕÐàßçèÕãÐâçÐéâìå×ÐîïÐå+äåÐì+â,ðãôÐðì
`ëäèÕíÐå+ÕÐéâßçåÐëä*ÐãâãÕå+ÕóÕììÐâçèÕçÐèðìéâÖÕç*ÐïçâëÐìßé+ÐìâßçéÕìÐðïÐå+Õ
`çÕHßÕìåðãôÐáäçå*Ðì+â,ìÐôââèÐéäßìÕíÐéâãìðèÕçðãôÐå+ÕÐóðëðåäåðâãìÐâïÐÔßóÕ
`ÙxÓàÝÓÙÝÓòÝ×ÐG+ÕÐéâßçåÐëä*ÐìáÕéðï*ÐéâãèðåðâãìÐïâçÐå+ÕÐèðìéâÖÕç*×
`
` 
`üJK"#L6!#!L'!5'"(
`ÐÐ .
`ÐwTlWSjRX\WT)f\XggQp]^)ÎÐáÕçìâãÐ,ðå++âóèðãôÐìßàáâÕãäÕèÐðãïâçëäåðâã
`ßãèÕçÐäÐéóäðëÐå+äåÐðåÐðìÐáçðÖðóÕôÕèÐâçÐìßàñÕéåÐåâÐáçâåÕéåðâãÐäìÐåçðäóyáçÕáäçäåðâã
`ëäåÕçðäóÐëßìå-
`ÐÐÐÐÐÐ
`ÐÕ2áçÕììó*ÐëäFÕÐå+ÕÐéóäðë/Ðäãè
`ÐÐÐÐÐÐ
`ÐèÕìéçðàÕÐå+ÕÐãäåßçÕÐâïÐå+ÕÐ,ðå++ÕóèÐèâéßëÕãåìíÐéâëëßãðéäåðâãìíÐâç
`åäãôðàóÕÐå+ðãôìÐðãÐäÐëäããÕçÐå+äåíÐ,ðå+âßåÐçÕÖÕäóðãôÐðãïâçëäåðâãÐðåìÕóï
`áçðÖðóÕôÕèÐâçÐáçâåÕéåÕèíÐ,ðóóÐÕãäàóÕÐå+ÕÐáäçåðÕìÐåâÐäììÕììÐå+ÕÐéóäðë×
`ÐÐ 0
`ÐwTlWSjRX\WT)iSW][UQ]^)îïÐðãïâçëäåðâãÐáçâèßéÕèÐðãÐçÕìáâãìÕÐåâÐä
`ìßàáâÕãäÐðìÐìßàñÕéåÐåâÐäÐéóäðëÐâïÐáçðÖðóÕôÕÐâçÐâïÐáçâåÕéåðâãÐäì
`åçðäóyáçÕáäçäåðâãÐëäåÕçðäóíÐå+ÕÐáÕçìâãÐëäFðãôÐå+ÕÐéóäðëÐëä*Ðãâåðï*Ðäã*Ðáäçå*
`å+äåÐçÕéÕðÖÕèÐå+ÕÐðãïâçëäåðâãÐâïÐå+ÕÐéóäðëÐäãèÐå+ÕÐàäìðìÐïâçÐðå×ÐÎïåÕçÐàÕðãô
`ãâåðïðÕèíÐäÐáäçå*ÐëßìåÐáçâëáåó*ÐçÕåßçãíÐìÕHßÕìåÕçíÐâçÐèÕìåçâ*Ðå+ÕÐìáÕéðïðÕè
`ðãïâçëäåðâãÐäãèÐäã*ÐéâáðÕìÐðåÐ+äì/ÐëßìåÐãâåÐßìÕÐâçÐèðìéóâìÕÐå+ÕÐðãïâçëäåðâã
`ßãåðóÐå+ÕÐéóäðëÐðìÐçÕìâóÖÕè/ÐëßìåÐåäFÕÐçÕäìâãäàóÕÐìåÕáìÐåâÐçÕåçðÕÖÕÐå+Õ
`ðãïâçëäåðâãÐðïÐå+ÕÐáäçå*ÐèðìéóâìÕèÐðåÐàÕïâçÕÐàÕðãôÐãâåðïðÕè/ÐäãèÐëä*Ðáçâëáåó*
`áçÕìÕãåÐå+ÕÐðãïâçëäåðâãÐßãèÕçÐìÕäóÐåâÐå+ÕÐéâßçåÐïâçÐå+ÕÐèðìåçðéåÐ,+ÕçÕ
`éâëáóðäãéÕÐðìÐçÕHßðçÕèÐïâçÐäÐèÕåÕçëðãäåðâãÐâïÐå+ÕÐéóäðë×ÐG+ÕÐáÕçìâãÐ,+â
`áçâèßéÕèÐå+ÕÐðãïâçëäåðâãÐëßìåÐáçÕìÕçÖÕÐå+ÕÐðãïâçëäåðâãÐßãåðóÐå+ÕÐéóäðëÐðì
`çÕìâóÖÕè×
`
`
`ü

÷
`
`G+ÕÐéâßçåÐïâçÐå+ÕÐèðìåçðéåÐ,+ÕçÕÐéâëáóðäãéÕÐðìÐçÕHßðçÕèIäãèÐäóìâíÐäïåÕçÐä
`ëâåðâãÐðìÐåçäãìïÕççÕèíÐå+ÕÐðììßðãôÐéâßçåIëä*Ð+âóèÐðãÐéâãåÕëáåÐäÐáÕçìâã
`,+âíÐ+äÖðãôÐàÕÕãÐìÕçÖÕèíÐïäðóìÐ,ðå+âßåÐäèÕHßäåÕÐÕ2éßìÕÐåâÐâàÕ*Ðå+Õ
`ìßàáâÕãäÐâçÐäãÐâçèÕçÐçÕóäåÕèÐåâÐðå×
`
`zâçÐäééÕììÐåâÐìßàáâÕãäÐëäåÕçðäóìíÐìÕÕÐzÕè×ÐÔ×ÐòðÖ×Ðæ×ÐÜhÓäÝÐòâëëðååÕÕÐ{âåÕÐÓÙØÛõÝ×
`
`

`

`Case 1:18-cv-00924-CFC Document 390 Filed 10/03/19 Page 9 of 212 PageID #: 29003
`Case 1:18—cv-00924-CFC Document 390 Filed 10/03/19 Page 9 of 212 PageID #: 29003
`
`}
`
`SCHEDULE A
`~€‚ƒ„…†…
`}
`Pursuant to Rule 45 of the Federal Rules of Civil Procedure, Plaintiff Genentech Inc.
`‡ˆ‰Šˆ‹Œ}Ž}ˆ‘}’“}Ž”}•‘}–‘—‘‰‹}ˆ‘Š}Ž”}˜™š™}‡‰Ž›‘—ˆ‰‘œ}‡‹™Œ™””}‘Œ‘Œ‘›•}žŒ›Ÿ}
`
`hereby requests that Cancer and Blood Specialty Clinic produce and permit inspection and
`•‘‰‘ ¡}‰‘¢ˆ‘ŠŠ}•‹}˜‹Œ›‘‰}‹Œ—}£ŽŽ—}¤¥‘›™‹¡}˜™Œ™›}¥‰Ž—ˆ›‘}‹Œ—}¥‘‰¦™}™ŒŠ¥‘›™ŽŒ}‹Œ—}
`
`copying of the following documents and things at the place, date and time specified in the
`›Ž¥¡™Œ§}Ž”}•‘}”ŽŽ¨™Œ§}—Ž›ˆ¦‘ŒŠ}‹Œ—}•™Œ§Š}‹}•‘}¥‹›‘œ}—‹‘}‹Œ—}™¦‘}Š¥‘›™”™‘—}™Œ}•‘}
`
`accompanying subpoena.
`‹››Ž¦¥‹Œ¡™Œ§}Šˆ ¥Ž‘Œ‹Ÿ}
`
`DEFINITIONS
`‚©ª«ª¬ª­«~…
`
`The words and phrases used in these Requests shall have the meanings ascribed to them
`®•‘}¨Ž‰—Š}‹Œ—}¥•‰‹Š‘Š}ˆŠ‘—}™Œ}•‘Š‘}‘¢ˆ‘ŠŠ}Š•‹}•‹š‘}•‘}¦‘‹Œ™Œ§Š}‹Š›‰™ ‘—}Ž}•‘¦}
`under the Federal Rules of Civil Procedure and the Local Rules of the United States District
`ˆŒ—‘‰}•‘}–‘—‘‰‹}ˆ‘Š}Ž”}˜™š™}‡‰Ž›‘—ˆ‰‘}‹Œ—}•‘}¯Ž›‹}ˆ‘Š}Ž”}•‘}°Œ™‘—}¤‹‘Š}±™Š‰™›}
`
`Court for the District of Delaware. In addition, the following terms shall have the meanings set
`˜Žˆ‰}”Ž‰}•‘}±™Š‰™›}Ž”}±‘‹¨‹‰‘Ÿ}}žŒ}‹——™™ŽŒœ}•‘}”ŽŽ¨™Œ§}‘‰¦Š}Š•‹}•‹š‘}•‘}¦‘‹Œ™Œ§Š}Š‘}
`
`forth below whenever used in any Request:
`”Ž‰•} ‘Ž¨}¨•‘Œ‘š‘‰}ˆŠ‘—}™Œ}‹Œ¡}‘¢ˆ‘Š²}
`
`1.
`“You,” “your,” and “yours” shall refer to, collectively or singly, to Cancer and
`|Ÿ³ ´µŽˆœ¶}´¡Žˆ‰œ¶}‹Œ—}´¡Žˆ‰Š¶}Š•‹}‰‘”‘‰}Žœ}›Ž‘›™š‘¡}Ž‰}Š™Œ§¡œ}Ž}˜‹Œ›‘‰}‹Œ—}
`
`Blood Specialty Clinic, its corporate parents, corporate predecessors, corporate successors, and
`£ŽŽ—}¤¥‘›™‹¡}˜™Œ™›œ}™Š}›Ž‰¥Ž‰‹‘}¥‹‰‘ŒŠœ}›Ž‰¥Ž‰‹‘}¥‰‘—‘›‘ŠŠŽ‰Šœ}›Ž‰¥Ž‰‹‘}Šˆ››‘ŠŠŽ‰Šœ}‹Œ—}
`
`all past or present subsidiaries, affiliates, divisions, units, departments, officers, directors,
`‹}¥‹Š}Ž‰}¥‰‘Š‘Œ}Šˆ Š™—™‹‰™‘Šœ}‹””™™‹‘Šœ}—™š™Š™ŽŒŠœ}ˆŒ™Šœ}—‘¥‹‰¦‘ŒŠœ}Ž””™›‘‰Šœ}—™‰‘›Ž‰Šœ}
`
`principals, agents, employees, representatives, assigns, attorneys, experts, insurers, and each
`¥‰™Œ›™¥‹Šœ}‹§‘ŒŠœ}‘¦¥Ž¡‘‘Šœ}‰‘¥‰‘Š‘Œ‹™š‘Šœ}‹ŠŠ™§ŒŠœ}‹Ž‰Œ‘¡Šœ}‘·¥‘‰Šœ}™ŒŠˆ‰‘‰Šœ}‹Œ—}‘‹›•}
`
`person acting or purporting to act on its behalf.
`¥‘‰ŠŽŒ}‹›™Œ§}Ž‰}¥ˆ‰¥Ž‰™Œ§}Ž}‹›}ŽŒ}™Š} ‘•‹”Ÿ}}
`2.
`“Plaintiff” or “our” shall refer to Genentech.
`¸Ÿ³ ´‡‹™Œ™””¶}Ž‰}´Žˆ‰¶}Š•‹}‰‘”‘‰}Ž}‘Œ‘Œ‘›•Ÿ}
`
`3.
`“Defendant,” “Amgen,” and “Amgen’s” shall refer, collectively or singly, to
`¹Ÿ³ ´±‘”‘Œ—‹Œœ¶}´º¦§‘Œœ¶}‹Œ—}´º¦§‘Œ»Š¶}Š•‹}‰‘”‘‰œ}›Ž‘›™š‘¡}Ž‰}Š™Œ§¡œ}Ž}
`
`Amgen Inc., and all of its corporate parents, corporate predecessors, corporate successors, and all
`º¦§‘Œ}žŒ›Ÿœ}‹Œ—}‹}Ž”}™Š}›Ž‰¥Ž‰‹‘}¥‹‰‘ŒŠœ}›Ž‰¥Ž‰‹‘}¥‰‘—‘›‘ŠŠŽ‰Šœ}›Ž‰¥Ž‰‹‘}Šˆ››‘ŠŠŽ‰Šœ}‹Œ—}‹}
`
`past or present subsidiaries, affiliates, divisions, units, departments, officers, directors, principals,
`¥‹Š}Ž‰}¥‰‘Š‘Œ}Šˆ Š™—™‹‰™‘Šœ}‹””™™‹‘Šœ}—™š™Š™ŽŒŠœ}ˆŒ™Šœ}—‘¥‹‰¦‘ŒŠœ}Ž””™›‘‰Šœ}—™‰‘›Ž‰Šœ}¥‰™Œ›™¥‹Šœ}
`
`agents, employees, representatives, assigns, attorneys, experts, insurers, and each person acting
`‹§‘ŒŠœ}‘¦¥Ž¡‘‘Šœ}‰‘¥‰‘Š‘Œ‹™š‘Šœ}‹ŠŠ™§ŒŠœ}‹Ž‰Œ‘¡Šœ}‘·¥‘‰Šœ}™ŒŠˆ‰‘‰Šœ}‹Œ—}‘‹›•}¥‘‰ŠŽŒ}‹›™Œ§}
`
`or purporting to act on its behalf
`Ž‰}¥ˆ‰¥Ž‰™Œ§}Ž}‹›}ŽŒ}™Š} ‘•‹”Ÿ}
`
`4.
`“Genentech” shall refer to Genentech, Inc.
`’Ÿ³ ´‘Œ‘Œ‘›•¶}Š•‹}‰‘”‘‰}Ž}‘Œ‘Œ‘›•œ}žŒ›Ÿ}
`
`5.
`“Person” means any natural person or any business, legal, or governmental entity
`“Ÿ³ ´‡‘‰ŠŽŒ¶}¦‘‹ŒŠ}‹Œ¡}Œ‹ˆ‰‹}¥‘‰ŠŽŒ}Ž‰}‹Œ¡} ˆŠ™Œ‘ŠŠœ}‘§‹œ}Ž‰}§Žš‘‰Œ¦‘Œ‹}‘Œ™¡}
`or association.
`Ž‰}‹ŠŠŽ›™‹™ŽŒŸ}
`
`}
`
`|}
`
`

`

`Case 1:18-cv-00924-CFC Document 390 Filed 10/03/19 Page 10 of 212 PageID #: 29004
`Case 1:18—cv-00924-CFC Document 390 Filed 10/03/19 Page 10 of 212 PageID #: 29004
`
`6.
`“Kanjinti” refers to the commercial name for Amgen’s trastuzumab biosimilar
`¼Ÿ³ ´½‹Œ¾™Œ™¶}‰‘”‘‰Š}Ž}•‘}›Ž¦¦‘‰›™‹}Œ‹¦‘}”Ž‰}º¦§‘Œ»Š}‰‹Šˆ¿ˆ¦‹ } ™ŽŠ™¦™‹‰}
`
`product.
`¥‰Ž—ˆ›Ÿ}
`
`7.
`“Document” means the complete original (or complete copy where the original is
`ÀŸ³ ´±Ž›ˆ¦‘Œ¶}¦‘‹ŒŠ}•‘}›Ž¦¥‘‘}Ž‰™§™Œ‹}ÁŽ‰}›Ž¦¥‘‘}›Ž¥¡}¨•‘‰‘}•‘}Ž‰™§™Œ‹}™Š}
`
`unavailable) and each non-identical copy (where different from the original because of notes
`ˆŒ‹š‹™‹ ‘Â}‹Œ—}‘‹›•}ŒŽŒÃ™—‘Œ™›‹}›Ž¥¡}Á¨•‘‰‘}—™””‘‰‘Œ}”‰Ž¦}•‘}Ž‰™§™Œ‹} ‘›‹ˆŠ‘}Ž”}ŒŽ‘Š}
`
`made on the copy or otherwise) of any writing or record, including but not limited to all written,
`¦‹—‘}ŽŒ}•‘}›Ž¥¡}Ž‰}Ž•‘‰¨™Š‘Â}Ž”}‹Œ¡}¨‰™™Œ§}Ž‰}‰‘›Ž‰—œ}™Œ›ˆ—™Œ§} ˆ}ŒŽ}™¦™‘—}Ž}‹}¨‰™‘Œœ}
`
`typewritten, handwritten, printed, electronic materials (including e-mail), or graphic matter of
`¡¥‘¨‰™‘Œœ}•‹Œ—¨‰™‘Œœ}¥‰™Œ‘—œ}‘‘›‰ŽŒ™›}¦‹‘‰™‹Š}Á™Œ›ˆ—™Œ§}‘æ‹™Âœ}Ž‰}§‰‹¥•™›}¦‹‘‰}Ž”}
`
`any kind or nature, however produced or reproduced, any form of collected data for use with
`‹Œ¡}ꌗ}Ž‰}Œ‹ˆ‰‘œ}•Ž¨‘š‘‰}¥‰Ž—ˆ›‘—}Ž‰}‰‘¥‰Ž—ˆ›‘—œ}‹Œ¡}”Ž‰¦}Ž”}›Ž‘›‘—}—‹‹}”Ž‰}ˆŠ‘}¨™•}
`
`electronic data processing equipment, and any mechanical or electronic visual or sound
`‘‘›‰ŽŒ™›}—‹‹}¥‰Ž›‘ŠŠ™Œ§}‘¢ˆ™¥¦‘Œœ}‹Œ—}‹Œ¡}¦‘›•‹Œ™›‹}Ž‰}‘‘›‰ŽŒ™›}š™Šˆ‹}Ž‰}ŠŽˆŒ—}
`
`recordings, including, without limitation, all tapes and discs, now or formerly in your possession,
`‰‘›Ž‰—™Œ§Šœ}™Œ›ˆ—™Œ§œ}¨™•Žˆ}™¦™‹™ŽŒœ}‹}‹¥‘Š}‹Œ—}—™Š›Šœ}ŒŽ¨}Ž‰}”Ž‰¦‘‰¡}™Œ}¡Žˆ‰}¥ŽŠŠ‘ŠŠ™ŽŒœ}
`
`custody or control, including all documents as defined in the broadest sense permitted by the
`›ˆŠŽ—¡}Ž‰}›ŽŒ‰Žœ}™Œ›ˆ—™Œ§}‹}—Ž›ˆ¦‘ŒŠ}‹Š}—‘”™Œ‘—}™Œ}•‘} ‰Ž‹—‘Š}Š‘ŒŠ‘}¥‘‰¦™‘—} ¡}•‘}
`Federal Rules of Civil Procedure.
`–‘—‘‰‹}ˆ‘Š}Ž”}˜™š™}‡‰Ž›‘—ˆ‰‘Ÿ}}
`
`8.
`“Including” means including but not limited to.
`ş³ ´žŒ›ˆ—™Œ§¶}¦‘‹ŒŠ}™Œ›ˆ—™Œ§} ˆ}ŒŽ}™¦™‘—}ŽŸ}
`
`9.
`“Produce” means to provide legible, complete, and exact copies of responsive
`Ɵ³ ´‡‰Ž—ˆ›‘¶}¦‘‹ŒŠ}Ž}¥‰Žš™—‘}‘§™ ‘œ}›Ž¦¥‘‘œ}‹Œ—}‘·‹›}›Ž¥™‘Š}Ž”}‰‘Š¥ŽŒŠ™š‘}
`
`documents to the undersigned counsel, or to make such documents available to the undersigned
`—Ž›ˆ¦‘ŒŠ}Ž}•‘}ˆŒ—‘‰Š™§Œ‘—}›ŽˆŒŠ‘œ}Ž‰}Ž}¦‹Ä‘}Šˆ›•}—Ž›ˆ¦‘ŒŠ}‹š‹™‹ ‘}Ž}•‘}ˆŒ—‘‰Š™§Œ‘—}
`
`counsel for inspection and reproduction.
`›ŽˆŒŠ‘}”Ž‰}™ŒŠ¥‘›™ŽŒ}‹Œ—}‰‘¥‰Ž—ˆ›™ŽŒŸ}
`
`10.
`“Relate to,” “relates to,” “refers to,” or “relating to” means relating to, referring
`|ǟ³ ´‘‹‘}Žœ¶}´‰‘‹‘Š}Žœ¶}´‰‘”‘‰Š}Žœ¶}Ž‰}´‰‘‹™Œ§}Ž¶}¦‘‹ŒŠ}‰‘‹™Œ§}Žœ}‰‘”‘‰‰™Œ§}
`
`to, mentioning, discussing, reflecting, containing, stating, describing, embodying, evidencing,
`Žœ}¦‘Œ™ŽŒ™Œ§œ}—™Š›ˆŠŠ™Œ§œ}‰‘”‘›™Œ§œ}›ŽŒ‹™Œ™Œ§œ}Š‹™Œ§œ}—‘Š›‰™ ™Œ§œ}‘¦ Ž—¡™Œ§œ}‘š™—‘Œ›™Œ§œ}
`
`constituting, dealing with, or making reference to in any way.
`›ŽŒŠ™ˆ™Œ§œ}—‘‹™Œ§}¨™•œ}Ž‰}¦‹Ä™Œ§}‰‘”‘‰‘Œ›‘}Ž}™Œ}‹Œ¡}¨‹¡Ÿ}
`
`11.
`“Thing” shall mean any physical specimen or other tangible item other than a
`||Ÿ³ ´®•™Œ§¶}Š•‹}¦‘‹Œ}‹Œ¡}¥•¡Š™›‹}Š¥‘›™¦‘Œ}Ž‰}Ž•‘‰}‹Œ§™ ‘}™‘¦}Ž•‘‰}•‹Œ}‹}
`
`document, in your possession, custody, or control.
`—Ž›ˆ¦‘Œœ}™Œ}¡Žˆ‰}¥ŽŠŠ‘ŠŠ™ŽŒœ}›ˆŠŽ—¡œ}Ž‰}›ŽŒ‰ŽŸ}}
`
`12.
`The terms “all,” “each,” and “any” shall be construed as all and any.
`|¸Ÿ³ ®•‘}‘‰¦Š}´‹œ¶}´‘‹›•œ¶}‹Œ—}´‹Œ¡¶}Š•‹} ‘}›ŽŒŠ‰ˆ‘—}‹Š}‹}‹Œ—}‹Œ¡Ÿ}
`
`13.
`The use of the singular form of any word shall include the plural form and vice
`|¹Ÿ³ ®•‘}ˆŠ‘}Ž”}•‘}Š™Œ§ˆ‹‰}”Ž‰¦}Ž”}‹Œ¡}¨Ž‰—}Š•‹}™Œ›ˆ—‘}•‘}¥ˆ‰‹}”Ž‰¦}‹Œ—}š™›‘}
`
`versa.
`š‘‰Š‹Ÿ}
`
`}
`
`¸}
`
`

`

`Case 1:18-cv-00924-CFC Document 390 Filed 10/03/19 Page 11 of 212 PageID #: 29005
`Case 1:18—cv-00924-CFC Document 390 Filed 10/03/19 Page 11 of 212 PageID #: 29005
`
`14.
`The words “and” and “or” shall be construed conjunctively or disjunctively as
`|’Ÿ³ ®•‘}¨Ž‰—Š}´‹Œ—¶}‹Œ—}´Ž‰¶}Š•‹} ‘}›ŽŒŠ‰ˆ‘—}›ŽŒ¾ˆŒ›™š‘¡}Ž‰}—™Š¾ˆŒ›™š‘¡}‹Š}
`
`necessary to make the request inclusive rather than exclusive.
`Œ‘›‘ŠŠ‹‰¡}Ž}¦‹Ä‘}•‘}‰‘¢ˆ‘Š}™Œ›ˆŠ™š‘}‰‹•‘‰}•‹Œ}‘·›ˆŠ™š‘Ÿ}
`
`15.
`The use of a verb in any tense shall be construed as the use of the verb in all other
`|“Ÿ³ ®•‘}ˆŠ‘}Ž”}‹}š‘‰ }™Œ}‹Œ¡}‘ŒŠ‘}Š•‹} ‘}›ŽŒŠ‰ˆ‘—}‹Š}•‘}ˆŠ‘}Ž”}•‘}š‘‰ }™Œ}‹}Ž•‘‰}
`tenses.
`‘ŒŠ‘ŠŸ}
`
`16.
`Words in the masculine, feminine, or neuter form shall include each of the other
`|¼Ÿ³ Ȏ‰—Š}™Œ}•‘}¦‹Š›ˆ™Œ‘œ}”‘¦™Œ™Œ‘œ}Ž‰}Œ‘ˆ‘‰}”Ž‰¦}Š•‹}™Œ›ˆ—‘}‘‹›•}Ž”}•‘}Ž•‘‰}
`
`genders.
`§‘Œ—‘‰ŠŸ}
`
`17.
`The use of any defin